Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Coregulator function: a key to understanding tissue specificity of selective receptor modulators.

Smith CL, O'Malley BW.

Endocr Rev. 2004 Feb;25(1):45-71. Review.

PMID:
14769827
2.

Molecular mechanisms of selective estrogen receptor modulator (SERM) action.

Dutertre M, Smith CL.

J Pharmacol Exp Ther. 2000 Nov;295(2):431-7. Review.

3.

Identification of tamoxifen-induced coregulator interaction surfaces within the ligand-binding domain of estrogen receptors.

Heldring N, Nilsson M, Buehrer B, Treuter E, Gustafsson JA.

Mol Cell Biol. 2004 Apr;24(8):3445-59.

5.

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.

Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA.

J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):279-85. Review.

PMID:
11162936
6.

Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.

Lewis JS, Jordan VC.

Mutat Res. 2005 Dec 11;591(1-2):247-63. Review.

PMID:
16083919
7.

The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors.

Johansson L, Båvner A, Thomsen JS, Färnegårdh M, Gustafsson JA, Treuter E.

Mol Cell Biol. 2000 Feb;20(4):1124-33.

8.
10.

Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

DuSell CD, Nelson ER, Wittmann BM, Fretz JA, Kazmin D, Thomas RS, Pike JW, McDonnell DP.

Mol Endocrinol. 2010 Jan;24(1):33-46. doi: 10.1210/me.2009-0339.

11.

Molecular determinants for the tissue specificity of SERMs.

Shang Y, Brown M.

Science. 2002 Mar 29;295(5564):2465-8.

12.
13.

Thoughts on tamoxifen resistant breast cancer. Are coregulators the answer or just a red herring?

Graham JD, Bain DL, Richer JK, Jackson TA, Tung L, Horwitz KB.

J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):255-9. Review.

PMID:
11162933
14.

CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.

Sauvé F, McBroom LD, Gallant J, Moraitis AN, Labrie F, Giguère V.

Mol Cell Biol. 2001 Jan;21(1):343-53.

16.

A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.

Zhang X, Jeyakumar M, Petukhov S, Bagchi MK.

Mol Endocrinol. 1998 Apr;12(4):513-24.

PMID:
9544987
17.

Corepressor recruitment by agonist-bound nuclear receptors.

White JH, Fernandes I, Mader S, Yang XJ.

Vitam Horm. 2004;68:123-43. Review.

PMID:
15193453
18.

Principles for modulation of the nuclear receptor superfamily.

Gronemeyer H, Gustafsson JA, Laudet V.

Nat Rev Drug Discov. 2004 Nov;3(11):950-64. Review.

PMID:
15520817
19.

Supplemental Content

Support Center